Patel Naimish — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Patel Naimish has filed 2 SEC Form 4 filings across 1 company in the last 90 days — active on both sides. Lifetime open-market purchases: $50K. Lifetime open-market sales: $363K.

Profile

Patel Naimish

Naimish Patel is the Chief Medical Officer at CRISPR Therapeutics AG, a company specializing in gene editing technologies. He has been involved in the development of therapeutics using the CRISPR/Cas9 platform, focusing on treatments for genetically defined diseases.

RoleInsider
Notability30/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-01CRSPCRISPR Therapeutics AGS — Open-market sale3.8K$55.62$211K
2026-06-01CRSPCRISPR Therapeutics AGM — Option exercise10.0K—
2026-03-17CRSPCRISPR Therapeutics AGS — Open-market sale3.1K$48.26$152K
2026-03-17CRSPCRISPR Therapeutics AGM — Option exercise8.1K—
2026-01-27CRSPCRISPR Therapeutics AGP — Open-market purchase1.5K$32.96$50K

Companies — Last 90 Days

Frequently Asked Questions

Who is Patel Naimish?

Naimish Patel is the Chief Medical Officer at CRISPR Therapeutics AG, a company specializing in gene editing technologies. He has been involved in the development of therapeutics using the CRISPR/Cas9 platform, focusing on treatments for genetically defined diseases.…

How many SEC Form 4 filings has Patel Naimish submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has Patel Naimish been buying or selling stock?

Recorded transactions: 1 open-market purchases ($50K) and 2 open-market sales ($363K) across all tracked filings.

Where can I see all of Patel Naimish's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Patel Naimish profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.